Nurix Therapeutics Inc [NRIX]
Données pivot
Statistiques pivot
| Métrique | Moyenne | Médiane | Écart type |
|---|---|---|---|
| Gain % | 32.51% | 29.51% | 25.43% |
| Perte % | -17.65% | -15.47% | 11.35% |
| Durée | 20.3d | 16d | 15.1d |
| Total des pivots trouvés | 46 |
| Segments gain/perte | 45 (22 Gain / 23 Perte) |
| Dernier pivot | Top @ $17.76 le 2026-05-29 |
| Variation depuis le dernier pivot | $-0.72 (-4.05%) |
Prévision du prochain pivot Dernier : $17.04
| Prochain type prévu | Bottom |
| Prix prévu (moy.) | $14.63 |
| Prix prévu (médiane) | $15.01 |
| Fourchette de prix prévue (~68%) | $12.61 - $16.64 |
| Variation vers cible moyenne | $-2.41 (-14.17%) |
| Date prévue (moy.) | 2026-06-18 |
| Plage de dates prévue (~68%) | 2026-06-03 - 2026-07-03 |
| Base | Based on 23 historical losses (Avg: -17.65%, Median: -15.47%, StdDev of Abs: 11.35%) and duration (Avg: 20.3 days, StdDev: 15.1 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Nurix Therapeutics Inc gained modestly, up 0.53%.
Nurix Therapeutics Inc (NRIX) stock price advanced on Monday after the stock rose $0.0900 (0.53%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 3.07% rise. Yesterday's trading volume was 2.68M shares, worth about $45.70M. This represents 118 926 shares more than the day before. Volume was below the 10-day average of 4.33M shares.
Nurix Therapeutics Inc signals
There is no conclusive signals given from RSI. The price is above both moving averages, but the short-term average remains below the long-term average; upward momentum is present but not yet fully confirmed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (23.3%), medium- (23.3%), and long-term (23.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Nurix Therapeutics Inc Support & Resistance Levels
The stock is approaching the closest resistance level at $17.50. approximately $0.460 (2.70%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $19. On a fall back there will be support at $15.6 The dis das resistance s115.6 -
Nurix Therapeutics Inc Evaluation
- Court score: 1.22
- Moyen score: 3.09
- Long score: 2.92